ARTBIO AS
Developing novel alpha radioligand therapies to redefine cancer care.
Overview
- 21
- Employees
- 74.3M NOK
- Revenue
- 2018
- Founded
Description
ARTBIO is a clinical-stage radiopharmaceutical company dedicated to advancing cancer treatment through a new class of alpha radioligand therapies (ARTs). Their core mission is to develop highly effective and safe therapies by focusing on specific tumor targets combined with the optimal alpha-precurs...